Procalcitonin test for lung severity in children
Part of Lungs & breathing clinical trials.
This study is checking if a blood test for procalcitonin (a sign of infection) can help measure how severe bronchiectasis is in children. It aims to find a way to better understand and manage this lung condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 and 17 years old.
- They must have bronchiectasis (abnormally widened lung airways) that was confirmed by a CT scan, and this should not be caused by cystic fibrosis.
- They must not have had a recent lung flare-up (called an exacerbation) in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an inhaled medication called CSL787 to see if it can help people with non-cystic fibrosis bronchiectasis (a lung condition that causes frequent infections and breathing problems). The study looks at different doses and checks how well the drug works and if it is safe.
This study looks at different types of bronchiectasis in Chinese patients to understand the disease better. It may involve additional tests like lung function and questionnaires.
This trial tests whether using a blood test called procalcitonin (which measures infection levels) can help doctors decide when to start and stop antibiotics for a lower respiratory tract infection (like pneumonia or bronchitis). The goal is to see if this approach works as well as the standard way of prescribing antibiotics.
This trial studies how well a non-invasive lung test can show lung involvement in people with asthma (especially IgE-related asthma) and people with cystic fibrosis. You might benefit by getting extra lung assessments without invasive procedures.
This study tests a new medicine for people with non-cystic fibrosis bronchiectasis. It aims to see if the drug can help reduce symptoms and improve quality of life.
This study looks at whether certain blood tests and CT scans can help predict when someone with bronchiectasis might have a flare-up (worsening of symptoms). It may help doctors better understand and manage the condition.
Hear when a new Non-cystic Fibrosis Bronchiectasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.